Загрузка...
Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer’s Disease and Not Associated with Cognitive Decline or Incident Dementia
Accumulating evidence suggests that disparate pathways from systemic metabolism to retinoic acid/vitamin A signaling can contribute to Alzheimer’s disease (AD) pathobiology. Retinol binding protein 4 (RBP4) is an adipocyte-secreted hormone (adipokine) that regulates insulin signaling and is also a k...
Сохранить в:
| Опубликовано в: : | J Alzheimers Dis |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6385158/ https://ncbi.nlm.nih.gov/pubmed/30562901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-180682 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|